Barclays PLC Prime Medicine, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Barclays PLC holds 84,697 shares of PRME stock, worth $283,734. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,697

Previous 19,104 343.35%

Holding current value

$283,734

Previous $98,000 234.69%

% of portfolio

0.0%

Previous 0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$3.41 - $6.7 $223,672 - $439,473	65,593 Added 343.35%	84,697 $328,000
Q2 2024 Aug 14, 2024	SELL	$4.3 - $8.03 $36,489 - $68,142	-8,486 Reduced 30.76%	19,104 $98,000
Q1 2024 May 15, 2024	SELL	$6.35 - $9.39 $169,195 - $250,196	-26,645 Reduced 49.13%	27,590 $193,000
Q4 2023 Feb 15, 2024	SELL	$5.59 - $9.55 $60,958 - $104,142	-10,905 Reduced 16.74%	54,235 $480,000
Q3 2023 Nov 07, 2023	BUY	$9.5 - $15.07 $543,979 - $862,923	57,261 Added 726.75%	65,140 $621,000
Q2 2023 Aug 03, 2023	BUY	$11.41 - $17.05 $29,015 - $43,358	2,543 Added 47.66%	7,879 $116,000
Q1 2023 May 04, 2023	BUY	$11.21 - $21.11 $28,574 - $53,809	2,549 Added 91.46%	5,336 $65,000
Q4 2022 Feb 13, 2023	BUY	$15.2 - $21.12 $42,362 - $58,861	2,787 New	2,787 $52,000

Others Institutions Holding PRME

# of Institutions

124

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $321M

More about PRME

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account